Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

INVISIO Interim Report January–June 2018: Growth and continued strategic initiatives

CEO comment ”In comparison with the second quarter of 2017 this year’s quarter is characterized by increased sales and an improved gross margin. We have a strong position in NATO and our long-term customer contracts answer for the quarter’s sound sales and very good order intake. The determined initiatives now taking place in product development and in the market are aimed at ensuring future expansion and in the short perspective will imply some strain on earnings”, says Lars Højgård Hansen, CEO of INVISIO.April–June 2018 · Revenue: SEK 93.8 m (84.2) · Gross profit: SEK 55.3 m (

C-RAD AB – Interim report January-June 2018

C-RAD AB – Interim report January-June 2018 PROFITABLE QUARTER, REVENUE INCREASED BY 61 PERCENT SECOND QUARTER 2018  · Order intake: 56.4 (49.3) MSEK, 14%. · Revenues: 51.9 (32.2) MSEK, 61%. · Operating profit: 2.0 (-4.1) MSEK. · Net results after tax: 1.6 (-4.3) MSEK · Result per share: 0.05 (-0.14) SEK. · Warrant program 2018/2021 fully subscribed Comments from Tim Thurn, CEO: SIGNIFICANT GROWTH IN REVENUE We are closing the second quarter with significant growth in revenue, an operating profit and a considerable increase in order intake. The result is

Idogen extends the project portfolio to projects in autoimmune diseases

Idogen AB (”Idogen”) announces today that the company has decided to expand its project portfolio with a third therapeutic area; autoimmune diseases. Idogen´s research department is currently evaluating the potential of the company's technology in a group of autoimmune diseases where there is a major medical need, and where a treatment has the potential to be granted orphan drug status.Idogen´s technology is designed for the development of tolerogenic cell therapy in a variety of areas, especially treatment of anti-drug antibodies, autoimmune diseases and organ rejection after

NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF IMPACT COATINGS AB (PUBL)

Shareholders in Impact Coatings AB (publ), org.nr 556544-5318, are hereby invited to attend the Extraordinary General Meeting of Shareholders (“EGM”) on Tuesday, 11 September 2018 at 09:00 a.m. at the company’s Certified Adviser, Redeye AB, located at Mäster Samuelsgatan 42 in Stockholm.Right to attend Shareholders who wish to attend the EGM shall both be registered in the shareholder registry maintained by Euroclear Sweden AB by Wednesday, 5 September 2018, and notify attendance to the company latest Wednesday, 5 September 2018 via e-mail to anmalan@impactcoatings.se or post to Impact

Finnair Plc - Managers' transactions – Vähähyyppä

Finnair Plc, Managers’ Transactions, 17 August 2018 at 09:08 am EET  ____________________________________________ Person subject to the notification requirement Name: Vähähyyppä, Pekka Position: Chief Financial Officer Issuer: Finnair Plc LEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATION Reference number: 213800SB6EOB8SSK9W63_20180816111427_69 ____________________________________________ Transaction date: 2018-08-14 Venue: XHEL Instrument type: SHARE ISIN: FI0009003230 Nature of the transaction: ACQUISITION Transaction details (

Finnair Plc - Managers' transactions – Vauramo

Finnair Plc, Managers’ Transactions, 17 August 2018 at 09:07 am EET  ____________________________________________ Person subject to the notification requirement Name: Vauramo, Pekka Position: Chief Executive Officer Issuer: Finnair Plc LEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATION Reference number: 213800SB6EOB8SSK9W63_20180816111427_68 ____________________________________________ Transaction date: 2018-08-14 Venue: XHEL Instrument type: SHARE ISIN: FI0009003230 Nature of the transaction: ACQUISITION Transaction details (1):

Finnair Plc - Managers' transactions – Suominen

Finnair Plc, Managers’ Transactions, 17 August 2018 at 09:06 am EET  ____________________________________________ Person subject to the notification requirement Name: Suominen, Arja Position: Other senior manager Issuer: Finnair Plc LEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATION Reference number: 213800SB6EOB8SSK9W63_20180816111427_70 ____________________________________________ Transaction date: 2018-08-14 Venue: XHEL Instrument type: SHARE ISIN: FI0009003230 Nature of the transaction: ACQUISITION Transaction details (1):

Finnair Plc - Managers' transactions – Schildt

Finnair Plc, Managers’ Transactions, 17 August 2018 at 09:05 am EET  ____________________________________________ Person subject to the notification requirement Name: Schildt, Jaakko Position: Other senior manager Issuer: Finnair Plc LEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATION Reference number: 213800SB6EOB8SSK9W63_20180816111427_74 ____________________________________________ Transaction date: 2018-08-14 Venue: XHEL Instrument type: SHARE ISIN: FI0009003230 Nature of the transaction: ACQUISITION Transaction details (1):

Finnair Plc - Managers' transactions – Karhu

Finnair Plc, Managers’ Transactions, 17 August 2018 at 09:04 am EET  ____________________________________________ Person subject to the notification requirement Name: Karhu, Piia Position: Other senior manager Issuer: Finnair Plc LEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATION Reference number: 213800SB6EOB8SSK9W63_20180816111427_75 ____________________________________________ Transaction date: 2018-08-14 Venue: XHEL Instrument type: SHARE ISIN: FI0009003230 Nature of the transaction: ACQUISITION Transaction details (1):

Finnair Plc - Managers' transactions – Järvinen

Finnair Plc, Managers’ Transactions, 17 August 2018 at 09:03 am EET ____________________________________________ Person subject to the notification requirement Name: Järvinen, Juha Position: Other senior manager Issuer: Finnair Plc LEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATION Reference number: 213800SB6EOB8SSK9W63_20180816111427_73 ____________________________________________ Transaction date: 2018-08-14 Venue: XHEL Instrument type: SHARE ISIN: FI0009003230 Nature of the transaction: ACQUISITION Transaction details (1):

Finnair Plc - Managers' transactions - Harra-Salonen

Finnair Plc, Managers’ Transactions, 17 August 2018 at 09:02 am EET ____________________________________________ Person subject to the notification requirement Name: Harra-Salonen, Katri Position: Other senior manager Issuer: Finnair Plc LEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATION Reference number: 213800SB6EOB8SSK9W63_20180816111427_72 ____________________________________________ Transaction date: 2018-08-14 Venue: XHEL Instrument type: SHARE ISIN: FI0009003230 Nature of the transaction: ACQUISITION Transaction details (

Interim report period from January 2018 to June 2018

2018 SECOND QUARTER (Apr-Jun) · Operating loss KSEK -3,563 (-2,559) · Loss per share SEK -0.04 (-0.12) 2018 FIRST HALF YEAR (Jan-Jun) · Operating loss KSEK -6,385 (-5,240) · Loss per share SEK -0.07 (-0.25)        IMPORTANT EVENTS DURING THE PERIOD · On March 22nd , the Company informed that it is close to obtaining CE mark for VagiVital®. This after the Company has received the report of the evaluation of its so called Technical File. The evaluation has been performed by Lloyd’s Register Quality Assurance, Ltd. (LRQA) in England, acting as the

Finnair Plc - Managers' transactions – Hakakari

Finnair Plc, Managers’ Transactions, 17 August 2018 at 09:01 am EET ____________________________________________ Person subject to the notification requirement Name: Hakakari, Eija Position: Other senior manager Issuer: Finnair Plc LEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATION Reference number: 213800SB6EOB8SSK9W63_20180816111427_71 ____________________________________________ Transaction date: 2018-08-14 Venue: XHEL Instrument type: SHARE ISIN: FI0009003230 Nature of the transaction: ACQUISITION Transaction details (1):

Cyxone’s interim report for January-June 2018

Summary of interim reportFirst Half-year (1 January to 30 June 2018) · Operating revenue KSEK 0 (0) · Income after financial items KSEK -6 503 (-4 075) · Earnings per share -0,37 (-0,27) · Cash and cash equivalents as of 30 June KSEK 17 817 (28 114) · Equity ratio as of 30 June 92,8 (95,2) % Second Quarter (1 April to 30 June 2018) · Operating revenue KSEK 0 (0) · Income after financial items KSEK -3 755 (-2 588) · Earnings per share -0,21 (-0,17) Significant events during the second quarter of 2018 · The company completed the acquisition of drug

BioGaia AB - Interim report January 1 – June 30, 2018

Comments from the Managing Director: “Our second quarter performance was very strong, with growth of 29% (26%, after foreign exchange effects) compared to the same quarter of last year. Thanks to solid growth in both the Pediatrics and Adult Health segments, we achieved sales of over SEK 200 million for the first time ever. Geographically, growth was strong across all three regions, EMEA, Asia Pacific and the Americas. At the same time, we would like to communicate that we foresee significantly lower royalty revenues from Nestlé as a consequence of the ongoing negotiations of our royalty

Boozt AB’s Half year report, January 1 – June 30 2018

Organic growth of 44% (constant currency 40%) in the second quarter with 43% growth in Boozt.com and 90% growth in Booztlet.com. Adjusted EBIT margin increased 2.7 percentage points to 4.9%. For the first six months organic growth was 38% and adjusted EBIT margin increased 1.5 percentage points to 2.4%. The revenue growth outlook for 2018 is adjusted upwards to more than 36% from previously more than 33%.SEK million  Apr 1 – Apr 1 –   Change Jan 1 – Jan 1 –   Change Jun 30, Jun 30, Jun 30, Jun 30, 2018 2017 2018

Webcast with Teleconference, Q2 / 2018

Nitro Games to host a Webcast with Teleconference on Monday 20 August 2018 09:30 Swedish time.Nitro Games Oyj interim report for Jan-June 2018 will be released on Monday 20 August 2018. After the release of the report, the Company will do a presentation. Participants can join this presentation by a Webcast or Teleconference. August 20th 2018 09:30 (Europe/Stockholm) Details of event: https://financialhearings.com/event/11379 Language: English Activity: Webcast with Teleconference Webcast: https://tv.streamfabriken.com/nitro-games-q2-2018 Teleconference: Dial-in number FI:

High level of orders received and improved operating profit

April – June 2018 ·  Net sales SEK 13,453 million (12,791) ·  Operating profit SEK 677 million (631) ·  Operating margin 5.0 percent (4.9) ·  Pre-tax profit SEK 673 million (617) ·  Earnings per share SEK 1.94 (1.78) ·  Orders received SEK 16,257 million (12,880) ·  Cash flow before financing SEK -704 million (-1,105) January – June 2018 ·  Net sales SEK 24,943 million (23,896) ·  Operating profit SEK 967 million (951) ·  Operating margin 3.9 percent (4.0) ·  Pre-tax profit SEK 929 million (928) ·  Earnings per share SEK 2.68 (2.72) ·  Orders

Acando Interim report January 1-June 30, 2018

Second quarter April 1–June 30, 2018 · Net sales totaled SEK 736 m (613) · Operating profit amounted to SEK 74 m (55) · Operating margin 10.1% (9.0) · Profit after tax was SEK 56 m (41) · Earnings per share were SEK 0.54 (0.40) Accumulated January 1–June 30, 2018 · Net sales totaled SEK 1,439 m (1,234) · Operating profit amounted to SEK 151 m (130) · Profit before non-recurring items SEK 155 m · Operating margin 10.5% (10.5) · Profit after tax was SEK 115 m (95) · Earnings per share were SEK 1.11 (0.93) · Cash and cash equivalents totaled SEK 27 m (

IMPACT COATINGS AB (PUBL), INTERIM REPORT APRIL-JUNE 2018

FINANCIAL RESULTS SECOND QUARTER  2018 · Net sales amounted to SEK 2 648 thousand (2 783) · Operating profit amounted to SEK -13 528 thousand (-13 998) · Net income after financial items amounted to SEK -13 527 thousand (-14 403) · Cash flow amounted to SEK -11 698 thousand (3 937) · Equity-to-assets ratio amounted to 77.9% (77.6%) FINANCIAL RESULTS FIRST HALF 2018 · Net sales amounted to SEK 9 788 thousand (21 234) · Operating profit amounted to SEK -19 628 thousand (-14 402) · Net income after financial items amounted to SEK -19 647 thousand (-14 408) ·

Resurs on list of equal opportunities companies

Resurs Holding has been recognised by the Indecap Q30 fund as one of 30 Swedish listed companies with the highest proportion of women in management positions. Based on these criteria, Indecap Q30 has chosen to invest in Resurs.Resurs Holding is one of 30 Swedish listed companies that Indecap Q30 has chosen to invest in to draw attention to companies with a high proportion of women in management positions in relation to their sector. Diversity and gender equality form one of six prioritised focus areas in Resurs’ sustainability efforts and the distinction confirms the importance of this area

Invitation to 2Q 2018 presentation

Otello Corporation ASA is presenting its 2Q 2018 results on Friday, August 24, 2018, at 08:00am CET. The presentation will take place at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway. A live webcast will be available at: https://otellocorp.com/ir Petter Lade, CFO  Phone: +47 91143878 E-mail: petterl@otellocorp.com About Otello: Otello holds shares in several different businesses, including (i)AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their businesses, capitalizing on a global

Improvements continue in Other Nordics

Second quarter: April-June 2018 ·  Operating revenue was SEK 1,696 M (1,678), an increase of 1%. Adjusted for the home care services business, which contributed to second quarter revenue last year, revenue increased by 5%. ·  Operating profit was SEK 78 M (60 excl. SEK 15 M in capital gain), an increase of SEK 18 M.   ·  Net profit after tax for the period was SEK 47 M (48). ·  Earnings per share for the period before and after dilution were SEK 0.88 (0.91). ·  Operating cash flow was SEK 143 M (45).   Interim period January-June 2018 ·  Operating revenue amounted

Gränges halts plans for a joint venture in North America

In September 2017, Gränges AB announced plans to form a joint venture with Mitsubishi Aluminum Co., Ltd in North America for manufacturing of advanced aluminium materials for brazed automotive heat exchangers. Gränges has decided to halt the plans for a joint venture in North America, as the project isn’t sufficiently attractive for Gränges from a risk-reward perspective given the current circumstances. Gränges and Mitsubishi will however continue the dialogue about future business opportunities. Gränges remains strongly committed to the North American market and our current expansion

There are no items matching the current filter
There are no more items matching the current filter
Back to top